Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumor Cell and Tumor Tissue Models for Predicting Effective Pancreatic Cancer Response

NCT03033927 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT03033927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03033927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumor Cell and Tumor Tissue Models for Predicting Effective Pancreatic Cancer Response
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Active, not recruiting
Start date
January 24, 2017
Completion date
January 24, 2027
Enrollment
74 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic adenocarcinoma, pancreatic cancer